A detailed history of Fluent Financial, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Fluent Financial, LLC holds 13,500 shares of DNA stock, worth $3,780. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,500
Previous 15,000 10.0%
Holding current value
$3,780
Previous $25,000 40.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$1.06 - $1.67 $1,590 - $2,505
-1,500 Reduced 10.0%
13,500 $15,000
Q4 2023

Jan 08, 2024

SELL
$1.26 - $1.79 $1,260 - $1,790
-1,000 Reduced 6.25%
15,000 $25,000
Q1 2023

May 10, 2023

BUY
$1.2 - $2.19 $19,200 - $35,040
16,000 New
16,000 $21,000
Q2 2022

Aug 04, 2022

BUY
$2.2 - $4.2 $22,000 - $42,000
10,000 New
10,000 $24,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $361M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Fluent Financial, LLC Portfolio

Follow Fluent Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fluent Financial, LLC with notifications on news.